Systematic ReviewPublished 12 October 2026Chinese medicine combined with EGFR-TKIs in EGFR-mutated advanced NSCLC: a meta-analysis of efficacy and safetyXiaohong Li · Die Qian · Shuai Liu · Mingmin Na · Bihong Dai · Chunping WanFrontiers in Oncologydoi 10.3389/fonc.2026.1942222
ReviewPublished 12 October 2026Spatial architecture shapes programmed cell death-associated immune niches and therapeutic resistance in clear cell renal cell carcinomaYu Yin · Junlong Wang · Dengxiong Li · Dandan QiuFrontiers in Oncologydoi 10.3389/fonc.2026.1952158
Original ResearchPublished 12 October 2026EGFR-TKI-associated colitis in non-small cell lung cancer: a retrospective characterization of clinical, radiographic, endoscopic, and histopathologic featuresShujun Wang · Chen Tan · Pufang Shi · Ya Li · Hefeng Zhan · Jiajing LiFrontiers in Pharmacologydoi 10.3389/fphar.2026.1935622
Original ResearchPublished 28 September 2026Integrative bioinformatics screening of a M2 macrophage-associated gene signature for osimertinib resistanceYajie Huang · Yaozhong Zhang · Jian ShiFrontiers in Geneticsdoi 10.3389/fgene.2026.1928986
ReviewPublished 25 September 2026CLDN18 and FGFR2 splicing variants are emerging tumor-associated antigens for cancer therapyMasuko Katoh · Masaru KatohFrontiers in Molecular Medicinedoi 10.3389/fmmed.2026.1927389
Original ResearchPublished 17 July 2026TRK immunohistochemistry in pediatric rhabdomyosarcomas: diagnostic and prognostic utility and limitationsRenáta Lajti · Katalin Dezső · Zoltán Sápi · Gergő Papp · Anna Mohás · Bence Bukovszky · Sándor Szabó · Luca Felkai · Monika CsókaPathology and Oncology Researchdoi 10.3389/pore.2026.1612374
Molecular MedicinePublished 6 September 2024Role of epigenetic in cancer biology, in hematologic malignancies and in anticancer therapyArmel Hervé Nwabo Kamdje · Hervet Paulain Dongmo Fogang · Patrice N. MimcheFrontiers in Molecular Medicinedoi 10.3389/fmmed.2024.1426454
